Company: PMVP
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030414
Chunk: 241

Company: PMV Pharmaceuticals, Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 8
Chunk 241
---
21

        $
        77

       The weighted average grant date fair value of stock options granted during the years ended December 31, 2024, 2023, and 2022, was $4.94, $4.03, and $10.92, respectively.The aggregate intrinsic value of options vested and exercisable as of December 31, 2024 and 2023 is calculated based on the difference between the exercise price and the fair value of the Company’s common stock.  The intrinsic value of options exercised in 2024, 2023, and 2022, was $107, $892, and $3,764, respectively.As of December 31, 2024, the total compensation cost related to nonvested service-based awards not yet recognized is $13,436. The weighted-average period over which the nonvested awards is expected to be recognized is 3.1 years.The Company estimated the fair value of stock options using the Black-Scholes options valuation model. The fair value of employee stock options is being amortized on a straight-line basis over the requisite service period of the awards. The fair value of employee stock options was estimated using the following assumptions: 

        Year Ended December 31,

        2024
         
        2023
         
        2022

        Risk-free interest rate
         
        3.57% - 4.69%
         
        3.45% - 4.65%
         
        1.48% - 4.34%

        Expected life (in years)
         
        5.50 - 6.25
         
        5.50 - 6.25
         
        5.50 - 6.44

        Dividend yield
         
        0%
         
        0%
         
        0%

        Expected volatility
         
        85.55% - 127.07%
         
        75.21% - 77.72%
         
        76.33% - 81.00%

       The weighted average assumptions used to estimate the fair value of stock purchase rights under the ESPP are as follows: 

        Year Ended December 31,

        2024
         
        2023
         
        2022

        Risk-free interest rate

        5.43%